POLITICO.eu September 16, 2026 • 14:15

Ozempic-maker turns to Anthropic to turbocharge medical research - politico.eu

By Dominic Giannini

The Danish pharma giant Novo said AI tools offer “completely new scientific opportunities.”

Thats not deterring Novo, however.
The Danish pharma giant said it would use the American artificial intelligence companys models and Claude Science to advance its research as it aims to become the … [+1117 chars]

Read Full Article on Original Site ↗ ← Back to News List

Ozempic-maker turns to Anthropic to turbocharge medical research - politico.eu

More from POLITICO.eu

Investors weigh whether Anthropic can sustain surging revenues post-IPO - Financial Times

Citing Trump, GOP regulators reject gas plant for Amazon data center - Politico

Stock Market Today: Dow Steady, Yields Edge Higher — Live Updates - WSJ

USPS made mail slower to cut costs. Midterm ballots will test the system. - Axios